Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 14, 2015; 21(18): 5598-5606
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5598
Table 3 Univariate and multivariate analyses of the factors associated with recurrence-free survival or overall survival for hepatocellular carcinoma patients
Category3-yr recurrence-free survival rateUnivariate analysisMultivariate analysis3-yr OS rateUnivariate analysisMultivariate analysis
P valueP value and HR (95%CI)P valueP value and HR (95%CI)
Gender0.3820.834
Male55.8%0.7511.38183.7%0.9811.121
Female57.1%0.670-2.84985.7%0.385-3.267
Age, yr0.1000.765
< 6057.3%0.4961.50883.4%0.7630.887
≥ 6051.2%0.925-2.46086.0%0.402-1.954
Smoking0.1360.618
Yes51.5%0.0761.48283.8%0.3741.237
No58.3%0.883-2.48584.1%0.536-2.854
Drinking0.5250.338
Yes52.2%0.4430.82987.0%0.7400.632
No57.1%0.466-1.47783.1%0.247-1.615
Family history0.1990.091
Yes66.7%0.2370.49791.7%0.1650.170
No55.3%0.171-1.44483.5%0.022-1.325
HBsAg status0.01010.266
Negative82.1%0.0063.01992.9%0.0572.374
Positive51.7%1.309-6.95982.6%0.517-10.895
AFP, ng/mL0.2790.972
> 40054.4%0.1840.78282.7%0.9481.012
≤ 40058.7%0.501-1.22084.8%0.508-2.018
Hepatic cirrhosis0.6350.01310.0311
Yes53.4%0.1761.12880.4%3.233
No63.5%0.686-1.85394.2%1.110-9.417
CTP class0.03210.147
A58.1%0.0112.13083.9%0.2622.321
B28.6%1.068-4.24685.7%0.745-7.233
Delta-NLR0.01910.146
> 1.64350.0%0.0091.80781.4%0.1611.765
≤ 1.64368.4%1.102-2.96289.5%0.820-3.799
Tumor nodules0.8910.625
Single57.5%0.3390.96083.9%0.3961.26
Multiple46.2%0.530-1.73684.6%0.499-3.185
Maximal tumor diameter0.0560.0191
> 5 cm47.4%0.0751.57375.4%0.02512.281
≤ 5 cm59.4%0.989-2.50387.4%1.148-4.536
Vascular invasion0.1760.5980.1630.792
Yes53.8%0.82876.9%1.144
No56.3%0.411-1.66985.1%0.420-3.113
Concomitant splenectomy0.7210.308
Yes37.5%0.0610.93975.0%0.3430.757
No57.6%0.665-1.32684.8%0.444-1.292
Intra-abdominal infection0.00010.0001
Yes24.0%< 0.0013.30852.0%< 0.00115.357
No60.6%1.806-6.06188.6%2.494-11.507